Circulating microRNA Testing for the Early Diagnosis and Follow-up of Colorectal Cancer Patients
暂无分享,去创建一个
J. Ju | Jingting Jiang | A. Fesler | H. Zhai | Haiyan Zhai
[1] Y. Toiyama,et al. Serum miR-200c Is a Novel Prognostic and Metastasis-Predictive Biomarker in Patients With Colorectal Cancer , 2014, Annals of surgery.
[2] O. Lingjaerde,et al. Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first‐line oxaliplatin‐based treatment , 2014, Molecular oncology.
[3] R. Biondi,et al. Differential Stability of Cell-Free Circulating microRNAs: Implications for Their Utilization as Biomarkers , 2013, PloS one.
[4] S. Rai,et al. A Plasma MicroRNA Panel for Detection of Colorectal Adenomas: A Step Toward More Precise Screening for Colorectal Cancer , 2013, Annals of surgery.
[5] Y. Akao,et al. Role of Intracellular and Extracellular MicroRNA-92a in Colorectal Cancer. , 2013, Translational oncology.
[6] Irene Moya,et al. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers. , 2013, Oncology reports.
[7] S. Juo,et al. The Functional Significance of MicroRNA-29c in Patients with Colorectal Cancer: A Potential Circulating Biomarker for Predicting Early Relapse , 2013, PloS one.
[8] Y. Toiyama,et al. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. , 2013, Journal of the National Cancer Institute.
[9] Chee Woon Wang,et al. Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer , 2013, BMC Cancer.
[10] H. Brenner,et al. Identification and Evaluation of Plasma MicroRNAs for Early Detection of Colorectal Cancer , 2013, PloS one.
[11] Xiao-Feng Sun,et al. Serum miR-21 and miR-92a as biomarkers in the diagnosis and prognosis of colorectal cancer , 2013, Tumor Biology.
[12] Li Li,et al. Dampening Enthusiasm for Circulating MicroRNA in Breast Cancer , 2013, PloS one.
[13] N. Miller,et al. Circulating miR‐34a levels are reduced in colorectal cancer , 2012, Journal of surgical oncology.
[14] Qinghua Xu,et al. Plasma miR-601 and miR-760 Are Novel Biomarkers for the Early Detection of Colorectal Cancer , 2012, PloS one.
[15] Qingyun Zhang,et al. The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors , 2012, Journal of Cancer Research and Clinical Oncology.
[16] R. Bast,et al. Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients , 2012, Cancer.
[17] Longgui Wang,et al. Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. , 2012, Cancer epidemiology.
[18] E. Kroh,et al. Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies , 2011, Cancer Prevention Research.
[19] M. Nykter,et al. Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis , 2011, PloS one.
[20] Tongyu Lin,et al. Circulating miR‐221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression , 2010, Journal of gastroenterology and hepatology.
[21] Jessica A. Weber,et al. Export of microRNAs and microRNA-protective protein by mammalian cells , 2010, Nucleic acids research.
[22] Zhaohui Huang,et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer , 2010, International journal of cancer.
[23] Chronic Disease Division. Cancer facts and figures , 2010 .
[24] Y. Matsuki,et al. Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells*♦ , 2010, The Journal of Biological Chemistry.
[25] Zhenghe Wang,et al. microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. , 2009, Cancer research.
[26] George A. Calin,et al. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases , 2009, Expert opinion on biological therapy.
[27] K. Ohuchida,et al. MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance , 2009, Molecular Cancer Therapeutics.
[28] E. Ng,et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening , 2009, Gut.
[29] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[30] R. Vyzula,et al. Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer , 2008, Oncology.
[31] Kazuhiko Hayashi,et al. Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. , 2007, RNA.
[32] G. Lutz,et al. Nanopolymers improve delivery of exon skipping oligonucleotides and concomitant dystrophin expression in skeletal muscle of mdx mice , 2008, BMC biotechnology.
[33] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[34] G. Ruvkun. Clarifications on miRNA and Cancer , 2006, Science.
[35] W. Filipowicz,et al. Inhibition of Translational Initiation by Let-7 MicroRNA in Human Cells , 2005, Science.
[36] C. Croce,et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[37] G. Ruvkun,et al. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans , 1993, Cell.
[38] V. Ambros,et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.
[39] Joon Cheol Park,et al. Plasma components affect accuracy of circulating cancer-related microRNA quantitation. , 2012, The Journal of molecular diagnostics : JMD.
[40] U. G. Dailey. Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.